Discovery of an unexpected function of the protein dDsk2
28 April 2015 | By Victoria White
A new function now described for the protein dDsk2 links ubiquitin receptors for the first time with the regulation of gene expression...
List view / Grid view
28 April 2015 | By Victoria White
A new function now described for the protein dDsk2 links ubiquitin receptors for the first time with the regulation of gene expression...
28 April 2015 | By Victoria White
Researchers at the Institut Hospital del Mar d’Investigacions Mèdiques (IMIM) have identified a new way of treating colorectal cancer...
28 April 2015 | By Victoria White
A team at CSHL has published results of experiments that lay bare a previously unknown pathway activated in HER2-positive breast cancer...
27 April 2015 | By Victoria White
4DMT and Roche are to collaborate to discover and develop optimised next-generation AAV vectors for indications with high unmet medical need...
27 April 2015 | By Victoria White
Stealth BioTherapeutics has expanded its ophthalmology programme, led by Ocuvia, with FDA granting a Type B meeting for inherited optic neuropathies...
27 April 2015 | By Victoria White
NanoViricides has discussed the significance of the effectiveness demonstrated by its anti-viral drug candidates in a lethal animal model of dermal herpes...
27 April 2015 | By Victoria White
Preclinical data from Synthetic Biologics’ novel SYN-005 programme for the treatment of Pertussis were presented in two posters at ECCMID 2015...
24 April 2015 | By Victoria White
arGEN-X and de Duve Institute/UCL/WELBIO have announced the publication of new data showing that ARGX-115 blocks the activity of GARP...
24 April 2015 | By Victoria White
AstraZeneca and Celgene collaborate for the development and commercialisation of MEDI4736 across a range of blood cancers, including non-Hodgkin’s lymphoma...
24 April 2015 | By Victoria White
New preclinical data demonstrates that BLU-554 has significant anti-tumour activity in models of HCC that are dependent on FGFR4 signalling...
23 April 2015 | By Victoria White
MRC Technology and NYU School of Medicine have signed an agreement to develop an antibody for the prevention of inflammatory osteolysis (bone breakdown)...
23 April 2015 | By Victoria White
Bayer and UKE are the main coordinators of a new international consortium, CANCER-ID, to develop novel blood-based biomarker technologies in cancer...
23 April 2015 | By Victoria White
Cytori Therapeutics presented data from two preclinical studies at ABA2015. The findings provide greater detail on Cytori's cell therapies...
23 April 2015 | By Victoria White
Dimension Therapeutics is advancing programmes to treat two rare diseases with often devastating outcomes for patients - OTC deficiency and GSDIa...
23 April 2015 | By Victoria White
An article describing an important scientific foundation for the clinical development of truly personalised cancer immunotherapies has been published...